Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Settings
NUVA [NASD]
NuVasive, Inc.
Index- P/E75.39 EPS (ttm)0.64 Insider Own1.60% Shs Outstand48.36M Perf Week3.25%
Market Cap2.33B Forward P/E35.56 EPS next Y1.36 Insider Trans-19.10% Shs Float47.50M Perf Month10.26%
Income33.10M PEG4.94 EPS next Q0.25 Inst Own99.00% Short Float6.57% Perf Quarter0.15%
Sales777.30M P/S3.00 EPS this Y-311.80% Inst Trans1.35% Short Ratio4.27 Perf Half Y11.95%
Book/sh13.66 P/B3.53 EPS next Y20.62% ROA2.60% Target Price53.73 Perf Year45.55%
Cash/sh5.98 P/C8.07 EPS next 5Y15.28% ROE5.20% 52W Range32.02 - 51.23 Perf YTD2.31%
Dividend- P/FCF153.51 EPS past 5Y-34.50% ROI1.20% 52W High-5.82% Beta0.99
Dividend %- Quick Ratio4.10 Sales past 5Y15.50% Gross Margin76.20% 52W Low50.69% ATR1.14
Employees1500 Current Ratio5.60 Sales Q/Q8.40% Oper. Margin8.90% RSI (14)65.12 Volatility1.73% 2.68%
OptionableYes Debt/Eq0.56 EPS Q/Q252.50% Profit Margin4.30% Rel Volume0.51 Prev Close48.23
ShortableYes LT Debt/Eq0.56 EarningsMay 04 AMC Payout0.00% Avg Volume730.51K Price48.25
Recom2.20 SMA205.02% SMA507.02% SMA20013.29% Volume375,533 Change0.04%
May-14-15Initiated Northland Capital Market Perform $46
Apr-15-15Downgrade Canaccord Genuity Buy → Hold $54 → $49
Feb-25-15Reiterated Brean Capital Buy $53 → $55
Jan-13-15Reiterated WallachBeth Buy $49 → $55
Jan-08-15Upgrade RBC Capital Mkts Sector Perform → Outperform $45 → $56
Dec-04-14Reiterated Brean Capital Buy $44 → $53
Sep-30-14Upgrade Brean Capital Hold → Buy $44
May-21-14Downgrade Needham Buy → Hold
Apr-30-14Reiterated RBC Capital Mkts Sector Perform $35 → $39
Apr-30-14Reiterated Canaccord Genuity Buy $51 → $48
Jan-22-14Reiterated Canaccord Genuity Buy $34 → $51
Jan-16-14Reiterated Barclays Equal Weight $35 → $38
Jan-09-14Reiterated Barclays Equal Weight $32 → $35
Dec-02-13Reiterated Barclays Equal Weight $30 → $32
Nov-15-13Reiterated Barclays Equal Weight $28 → $30
Oct-30-13Reiterated Needham Buy $28 → $35
Oct-30-13Reiterated Barclays Equal Weight $23 → $28
Aug-08-13Initiated Needham Buy $28
Jul-31-13Reiterated Canaccord Genuity Buy $29 → $32
Jun-19-13Reiterated Canaccord Genuity Buy $24.50 → $29
May-14-15 01:38PM  Coverage initiated on NuVasive by Northland Capital
May-08-15 03:45PM  Is NuVasive (NUVA) Worth Adding to Your Portfolio Now? - Analyst Blog
May-07-15 05:45PM  CORRECTION - NuVasive(R) to Participate in Investor Events in May 2015 Marketwired
04:05PM  NuVasive(R) to Participate in Investor Events in May 2015 Marketwired
May-06-15 08:12PM  10-Q for NuVasive, Inc. at Company Spotlight
May-05-15 01:08PM  Correction: Earns-NuVasive story
12:40PM  NuVasive Tops Q1 Earnings on High Revenues; Margins Rise - Analyst Blog
11:15AM  NuVasive attracts bullish strategy
May-04-15 05:54PM  NuVasive tops Street 1Q forecasts
04:30PM  NuVasive Inc Earnings Call scheduled for 4:30 pm ET today
04:24PM  NuVasive Reports First Quarter 2015 Financial Results at noodls
04:21PM  NUVASIVE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  NuVasive Reports First Quarter 2015 Financial Results Marketwired
09:23AM  NuVasive(R) Launches Integrated Global Alignment (iGA(TM)) Platform at AANS 2015 at noodls
08:00AM  NuVasive(R) Launches Integrated Global Alignment (iGA(TM)) Platform at AANS 2015 Marketwired
07:07AM  Q1 2015 NuVasive Inc Earnings Release - After Market Close
Apr-30-15 06:30AM  NUVASIVE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Apr-29-15 08:31AM  NuVasive(R) Reaches Agreement in Principle to Settle OIG Matter at noodls
08:00AM  NuVasive(R) Reaches Agreement in Principle to Settle OIG Matter Marketwired
Apr-27-15 04:27PM  NuVasive to Launch Game-Changing Surgical Platform at the American Association of Neurological Surgeons 83rd Annual Meeting at noodls
04:05PM  NuVasive to Launch Game-Changing Surgical Platform at the American Association of Neurological Surgeons 83rd Annual Meeting Marketwired
Apr-15-15 08:39AM  Analysts' Actions -- Ameriprise, Intel, NuVasive and More
Apr-14-15 02:30PM  NuVasive Poised on Balanced Growth, International Expansion - Analyst Blog
Apr-13-15 04:17PM  Jefferies: 10 Buyout Targets To Own During The M&A Boom
Apr-08-15 06:13PM  NuVasive Announces Conference Call and Webcast of First Quarter 2015 Results at noodls
04:05PM  NuVasive Announces Conference Call and Webcast of First Quarter 2015 Results Marketwired
Apr-02-15 07:16AM  NuVasive CEO Departure a Mark of Maturity at Barrons.com -7.08%
Apr-01-15 04:41PM  NuVasive CEO Lukianov out after expense reimbursement probe
12:37PM  NuVasive CEO Lukianov resigns after reimbursement probe
09:44AM  NuVasive CEO resigns after probe finds policy violations at MarketWatch
09:40AM  NuVasive CEO Resigns After Probe at The Wall Street Journal
08:50AM  NuVasive Announces Leadership Transition at noodls
08:45AM  NuVasive CEO resigns after investigation shows policy violations
08:36AM  NUVASIVE INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal Offi
08:30AM  NuVasive Announces Leadership Transition Marketwired
Mar-10-15 02:31PM  NuVasive Reports Fourth Quarter and Full Year 2014 Financial Results at noodls
Mar-03-15 04:25PM  NUVASIVE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
02:47PM  NuVasive: Court Overturns Medtronic Award at The Wall Street Journal
01:04PM  NUVASIVE INC Financials
08:20AM  NuVasive Announces Successful Appeal of Medtronic Verdict at noodls
08:00AM  NuVasive Announces Successful Appeal of Medtronic Verdict Marketwired
Feb-27-15 07:08PM  10-K for NuVasive, Inc. at Company Spotlight
05:46PM  NuVasive to Participate in Investor Events in March 2015 at noodls
Feb-26-15 04:05PM  NuVasive to Participate in Investor Events in March 2015 Marketwired
Feb-25-15 06:20AM  NUVASIVE INC Files SEC form 10-K, Annual Report EDGAR Online -6.11%
Feb-24-15 05:48PM  NuVasive beats Street 4Q forecasts AP
05:30PM  NuVasive Inc Earnings Call scheduled for 5:30 pm ET today CCBN
04:30PM  NUVASIVE INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements an EDGAR Online
04:06PM  NuVasive Announces Updated Non-GAAP Definition Marketwired
04:05PM  NuVasive Reports Fourth Quarter and Full Year 2014 Financial Results Marketwired
07:07AM  Q4 2014 NuVasive Inc Earnings Release - After Market Close CCBN
Feb-04-15 04:05PM  NuVasive to Participate in Investor Event in February 2015 Marketwired
Jan-12-15 04:05PM  NUVASIVE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
04:01PM  NuVasive Announces Expanded Leadership Roles for Executives Pat Miles and Matt Link Marketwired
04:00PM  NuVasive Announces Select Preliminary Unaudited Full-Year 2014 Financial Results and 2015 Outlook Marketwired
Jan-08-15 03:17PM  Spinal Products Firm NuVasive Ripe For Expansion at Investor's Business Daily
08:50AM  Analysts' Actions: Boston Scientific, Dick's, NuVasive, Zumiez TheStreet
Jan-05-15 04:05PM  NuVasive to Participate in Investor Event in January 2015 Marketwired
Dec-24-14 04:55AM  Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 PR Newswire
Nov-24-14 04:05PM  NuVasive to Participate in Investor Events in December 2014 Marketwired
Nov-17-14 10:00AM  NuVasive (NUVA) Flagged As Strong On High Volume at TheStreet
Nov-14-14 07:14AM  NuVasive (NUVA) Shares March Higher, Can It Continue? Zacks
Nov-10-14 04:05PM  NuVasive(R) Focused on Surgeon Support and Showcasing Industry-Leading Products at North American Spine Society 29th Annual Meeting Marketwired
Nov-05-14 11:24AM  Insider Trading Alert - SANM, NUVA And EMC Traded By Insiders at TheStreet
Nov-03-14 04:05PM  NuVasive to Host Investor Morning on November 13, 2014 Marketwired
Nov-01-14 08:07PM  10-Q for NuVasive, Inc. Company Spotlight
Oct-30-14 06:04PM  NuVasive reports 3Q loss AP
05:30PM  NuVasive Inc Earnings Call scheduled for 5:30 pm ET today CCBN
04:18PM  NUVASIVE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  NuVasive Reports Third Quarter 2014 Financial Results and Increases Full Year Guidance Marketwired
07:07AM  Q3 2014 NuVasive Inc Earnings Release - After Market Close CCBN
Oct-16-14 04:30PM  NuVasive Announces Conference Call and Webcast of Third Quarter 2014 Results Marketwired
Oct-01-14 08:30AM  NuVasive(R) Demonstrates Expanding EMEA Business at Eurospine 2014 With Surgeon Workshops and Innovative Product Exhibition Marketwired
Sep-30-14 09:31AM  Will This Analyst Upgrade Help NuVasive (NUVA) Stock Today? at TheStreet
08:40AM  Analysts' Actions: China Mobile Games, Kellogg, Nuvasive and More TheStreet
Sep-16-14 12:50PM  St. Jude Medical Gets Award for Leadless Pacemaker Again Zacks
Sep-08-14 03:50PM  Is Abaxis (ABAX) a Buy After Solid Q2 Earnings? Zacks
10:37AM  NuVasive Spine Foundation(TM) Exceeds $13 Million in Global Effort to Support Patients in Need Marketwired
Aug-27-14 12:30PM  Greatbatch to See Sluggish Top Line Growth Zacks
Aug-25-14 03:45PM  ResMed Continues to Disappoint despite OSA Market Potential Zacks
Aug-05-14 04:30PM  NuVasive(R) to Participate in Investor Events in August and September 2014 Marketwired
Aug-04-14 04:31PM  NUVASIVE INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Aug-01-14 12:14PM  Bob McNamara, the Executive Vice President and CFO of LDR Holding Corporation (LDRH), Interviews with The Wall Street Transcript Wall Street Transcript
10:04AM  Insider Trading Alert - REX, NUVA And CIEN Traded By Insiders at TheStreet
Jul-30-14 09:22AM  Will This Price Target Increase Help NuVasive (NUVA) Stock Today? at TheStreet +9.01%
Jul-29-14 05:30PM  NuVasive Inc Earnings Call scheduled for 5:30 pm ET today CCBN
04:34PM  NUVASIVE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:30PM  NuVasive Reports Second Quarter 2014 Financial Results and Increases Full Year Guidance Marketwired
07:07AM  Q2 2014 NuVasive CCBN
Jul-15-14 04:30PM  NuVasive(R) Announces Conference Call and Webcast of Second Quarter 2014 Results Marketwired
Jul-14-14 10:17AM  Insider Trading Alert - NUVA, TUES And KR Traded By Insiders at TheStreet
Jul-09-14 08:30AM  NuVasive(R) to Participate in the 21st Annual International Meeting on Advanced Spine Techniques (IMAST) Marketwired
Jul-07-14 12:00PM  NuVasive(R) Names Carol Cox Executive Vice President Strategy and Corporate Communications Marketwired
Jul-03-14 10:14AM  Insider Trading Alert - CSC, NUVA And BAS Traded By Insiders at TheStreet
Jun-26-14 09:29AM  Will This Analyst Upgrade Help NuVasive (NUVA) Stock Today? at TheStreet
Jun-25-14 12:30PM  Insider Trading Alert - DVN, NUVA And SWN Traded By Insiders
11:15AM  Insider Trading Alert - DVN, NUVA And SWN Traded By Insiders at TheStreet
Jun-23-14 08:30AM  NuVasive(R) Announces the Release of the Next Generation Monitoring Platform for Spine Surgery Marketwired
May-29-14 07:57AM  NuVasive would have negative read through from Stryker deal, says RBC Capital at theflyonthewall.com
May-21-14 09:50AM  NuVasive management to meet with Piper Jaffray at theflyonthewall.com
NuVasive, Inc., a medical device company, develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for the spine. Its products focus on applications for spine fusion surgery. The company's principal product is Maximum Access Surgery (MAS), a minimally-disruptive surgical platform that includes its proprietary software-driven nerve detection and avoidance systems, NVM5 and NVJJB, and intra-operative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The company's biologic product line offerings used to aid the spinal fusion process or bone healing process consist of Osteocel Plus and Osteocel Pro allograft (donated human tissue), which are cellular matrix products containing viable mesenchymal stem cells; FormaGraft, a collagen synthetic product; and AttraX, a synthetic bone graft material. It also provides IOM services for insight into the nervous system during non-spine. The company sells its products through independent sales agencies, directly-employed sales shareowners to surgeons and hospitals in the United States and internationally. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Miles PatrickPresident and COOMay 19Sale47.5215,000712,79192,488May 20 05:16 PM
Miles PatrickPresident and COOMay 18Option Exercise34.82118,0484,110,431210,536May 20 05:16 PM
Link MatthewPresident, U.S. Sales and Svc.May 04Sale44.305,460241,87856,093May 06 04:10 PM
Powers RussellEVP, InternationalMay 01Option Exercise26.624,016106,90677,498May 01 05:42 PM
Powers RussellEVP, InternationalMay 01Sale44.442,410107,09075,088May 01 05:42 PM
Powers RussellEVP, InternationalApr 29Sale45.409,471430,02173,482May 01 05:42 PM
Powers RussellEVP, InternationalApr 24Option Exercise26.628,484225,84486,328Apr 28 04:47 PM
Powers RussellEVP, InternationalApr 24Sale44.073,888171,34482,440Apr 28 04:47 PM
Miles PatrickPresident and COOMar 13Sale45.527,920360,51791,688Mar 16 04:47 PM
Miles PatrickPresident and COOMar 12Option Exercise32.8058,1491,907,287149,837Mar 16 04:47 PM
Lukianov Alexis VChairman & CEOMar 09Sale44.825,313238,102328,367Mar 10 04:55 PM
Lukianov Alexis VChairman & CEOMar 06Option Exercise18.3118,750343,313347,117Mar 10 04:55 PM
Hannon JasonEVP, General Counsel & Sec.Mar 06Sale44.673,615161,48244,273Mar 10 04:55 PM
Link MatthewPresident, U.S. Sales and Svc.Mar 03Sale44.467,500333,43160,753Mar 03 05:27 PM
Hannon JasonEVP, General Counsel & Sec.Mar 02Sale45.065,085229,10647,888Mar 03 05:26 PM
Hannon JasonEVP, General Counsel & Sec.Feb 23Sale47.991,82287,43849,264Feb 25 04:17 PM
Hannon JasonEVP, General Counsel & Sec.Feb 17Sale46.9913,178619,25151,086Feb 19 04:49 PM
Lukianov Alexis VChairman & CEOFeb 09Sale46.105,454251,405302,866Feb 10 04:13 PM
Lukianov Alexis VChairman & CEOFeb 06Option Exercise18.3118,750343,313321,616Feb 10 04:13 PM
Link MatthewPresident, U.S. Sales and Svc.Feb 05Sale46.192,05494,87467,655Feb 05 04:10 PM
Link MatthewPresident, U.S. Sales and Svc.Feb 04Option Exercise26.6212,240325,82977,871Feb 05 04:10 PM
Link MatthewPresident, U.S. Sales and Svc.Feb 04Sale45.352,02491,78867,655Feb 05 04:10 PM
Miles PatrickPresident and COOFeb 03Sale45.5315,000683,00384,651Feb 03 04:48 PM
Miles PatrickPresident and COOFeb 02Option Exercise30.9596,1332,974,913155,114Feb 03 04:48 PM
Valentine KeithCOOJan 28Sale46.966,970327,27888,934Jan 29 04:31 PM
Valentine KeithCOOJan 27Option Exercise38.9465,5772,553,568154,511Jan 29 04:31 PM
Hannon JasonEVP, General Counsel & Sec.Jan 05Sale46.032,11797,44632,240Jan 05 05:11 PM
Miles PatrickPresident, Global Prod & SvcsJan 05Sale46.6115,000699,11048,973Jan 05 05:03 PM
Hannon JasonEVP, General Counsel & Sec.Jan 02Option Exercise23.246,754156,96338,994Jan 05 05:11 PM
Miles PatrickPresident, Global Prod & SvcsJan 02Option Exercise26.6259,6211,587,111108,594Jan 05 05:03 PM
Hannon JasonEVP, General Counsel & Sec.Jan 02Sale46.9910,000469,90022,240Jan 05 05:11 PM
Hannon JasonEVP, General Counsel & Sec.Dec 30Sale47.6511,854564,79629,779Dec 31 04:11 PM
Hannon JasonEVP, General Counsel & Sec.Dec 29Option Exercise23.2448,1861,119,84377,965Dec 31 04:11 PM
Hannon JasonEVP, General Counsel & Sec.Dec 29Sale47.573,146149,65529,779Dec 31 04:11 PM
Miles PatrickPresident, Global Prod & SvcsDec 24Sale47.5215,000712,84247,501Dec 29 05:15 PM
Miles PatrickPresident, Global Prod & SvcsDec 23Option Exercise24.0964,9591,565,12696,046Dec 29 05:15 PM
Valentine KeithCOODec 19Sale47.785,893281,55886,471Dec 22 05:25 PM
Valentine KeithCOODec 18Option Exercise18.3120,000366,200106,471Dec 22 05:25 PM
Hannon JasonEVP, General Counsel & Sec.Dec 12Option Exercise23.245,060117,59435,474Dec 15 05:18 PM
Valentine KeithCOODec 11Option Exercise23.9233,442799,89488,702Dec 15 05:15 PM
Valentine KeithCOODec 01Sale43.662,500109,15070,236Dec 02 05:29 PM
Blackford Quentin S.CFO and CAONov 19Sale43.417,698334,178800Nov 20 04:54 PM
Valentine KeithCOONov 19Sale43.325,582241,79572,736Nov 20 04:49 PM
Valentine KeithCOONov 18Option Exercise18.3120,000366,20092,736Nov 20 04:49 PM
Blackford Quentin S.CFO and CAONov 18Option Exercise29.9511,458343,1677,820Nov 20 04:54 PM
Lukianov Alexis VChairman & CEONov 07Option Exercise18.3125,000457,750201,838Nov 10 04:36 PM
Lukianov Alexis VChairman & CEONov 07Sale41.4025,0001,034,993176,838Nov 10 04:36 PM
Miles PatrickPresident, Global Prod & SvcsNov 04Option Exercise20.6929,744615,26462,914Nov 06 05:08 PM
Miles PatrickPresident, Global Prod & SvcsNov 04Sale41.2429,7441,226,60747,501Nov 06 05:08 PM
Valentine KeithCOONov 03Sale40.612,500101,52572,736Nov 04 04:29 PM
Valentine KeithCOOOct 20Option Exercise9.501,33412,67376,119Oct 21 04:57 PM
Valentine KeithCOOOct 20Sale34.9688330,86775,236Oct 21 04:57 PM
Blackford Quentin S.CFO and CAOOct 03Sale36.305,000181,51312,902Apr 08 05:52 PM
Valentine KeithCOOOct 02Sale35.002,50087,50074,785Oct 06 05:00 PM
Valentine KeithPresident & COOSep 02Sale35.142,50087,85077,285Sep 03 04:28 PM
Valentine KeithPresident & COOAug 01Sale37.112,50092,77579,785Aug 05 04:47 PM
LAMBERT MICHAELEVP & CFOAug 01Sale37.114,010148,81113,631Aug 05 04:46 PM
Hannon JasonEVP, General Counsel & Sec.Jul 30Sale39.005,000195,00030,390Jul 31 05:22 PM
Powers RussellEVP, InternationalJul 10Sale33.433,200106,97642,984Jul 11 06:40 PM
LAMBERT MICHAELEVP & CFOJul 01Sale35.4823,225823,93017,641Jul 02 06:50 PM
Valentine KeithPresident & COOJul 01Sale35.652,50089,12582,285Jul 02 06:44 PM
Valentine KeithPresident & COOJun 20Sale35.005,000175,00084,785Jun 24 06:43 PM
Powers RussellEVP, InternationalJun 20Sale35.009,526333,41043,281Jun 24 06:40 PM